Why is "Larimar" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-06-30 11:29:06
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Larimar entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-06-30 and was most recently seen on 2026-06-30.
Wikipedia Overview
Larimar is the tradename for a rare blue variety of the silicate mineral pectolite found only in the Dominican Republic, around the city of Barahona. Its coloration varies from bluish white, light-blue, light-green, green-blue, turquoise blue, turquoise green, turquoise blue-green, deep green, dark green, to deep blue, dark blue and purple, violet and indigo and the larimar can come in many varieties and color mixes.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Larimar Therapeutics (LRMR) Submits Initial Module of BLA For Nomlabofusp Therapy - Yahoo Finance
-
170 Larimar Dr, Willowick, OH 44095 - Realtor.com
-
Price to earnings forward of Larimar Therapeutics, Inc. – LS:A2P5PP - TradingView
-
Larimar Therapeutics faces securities fraud pro... - Pluang
-
Larimar Therapeutics submits rolling BLA for nomlabofusp - The Pharma Letter
-
Larimar Therapeutics Reports First Quarter 2026 Financial and Business Update - GlobeNewswire
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR - YCharts
-
Larimar to discuss Friedreich’s ataxia drug data June 29 - Stock Titan
-
Larimar Moonstone Blue Topaz Pendant: 925 Sterling Silver Healing Crystal - aviglianonews.it
-
H.C. Wainwright initiates Larimar stock coverage with buy rating - Investing.com
-
Larimar Therapeutics Shares Drop Following Clinical Update and Regulatory Filing (LRMR) - Yahoo Finance
-
Larimar Therapeutics (LRMR) director purchases 50,000 common shares - Stock Titan
-
Larimar Therapeutics Publishes Cross-Species Findings Supporting Skin as a Surrogate for the Measurement of Frataxin in Tissues Clinically Relevant to Friedreich’s Ataxia - GlobeNewswire
-
Here’s What Citi Thinks About Larimar Therapeutics (LRMR) - Yahoo Finance
-
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering - GlobeNewswire
-
Wedbush Raises its Price Target on Larimar Therapeutics (LRMR) to $13 - Yahoo Finance
-
Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering - GlobeNewswire
-
Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia - Yahoo Finance
-
Island Notes from a Woofer – From Sweet Basil to Legends to Larimar - The San Pedro Sun
-
Larimar's Rare Disease Push Just Hit A Key Inflection Point — What Investors Need To Know - Yahoo Finance
-
Larimar's Rare Disease Push Just Hit A Key Inflection Point — What Investors Need To Know - Stocktwits
-
Why is Larimar Therapeutics stock sliding today? - Investing.com
-
Citi Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $14 - Moomoo
-
Larimar Therapeutics Announces FDA Breakthrough Therapy - GlobeNewswire
-
Larimar’s Friedreich’s Ataxia Drug Troubled by Anaphylaxis Concerns; Shares Fall - BioSpace
-
LRMR News | LARIMAR THERAPEUTICS INC (NASDAQ:LRMR) - ChartMill
-
Larimar Therapeutics, Inc. (LRMR) Discusses Regulatory Progress and Long-Term Data for Nomlabofusp in Friedreich's Ataxia - Slideshow (NASDAQ:LRMR) 2026-07-01 - Seeking Alpha
-
Larimar Signs Agreement With Point for the Outdoor Furnishing of Residences and Shared Spaces Within the Complex - Business Wire
-
Baird Initiates Larimar Therapeutics(LRMR.US) With Buy Rating, Announces Target Price $5 - Moomoo
-
Here's Why We're Watching Larimar Therapeutics' (NASDAQ:LRMR) Cash Burn Situation - Moomoo
-
Larimar Therapeutics, Inc. Prices Upsized Public Offering of 20 Million Shares at $5.00 Each - Quiver Quantitative
-
Larimar Therapeutics Stock (LRMR) Opinions on Public Offering and Insider Purchases - Quiver Quantitative
-
Larimar Therapeutics (LRMR) Valuation After FDA Breakthrough Therapy Designation For Nomlabofusp - simplywall.st
-
Rare ataxia drug nomlabofusp heads for FDA filing and possible 2027 launch - Stock Titan
-
Here's Why We're Watching Larimar Therapeutics' (NASDAQ:LRMR) Cash Burn Situation - Yahoo Finance
-
Larimar Therapeutics, Inc.(NasdaqGM: LRMR) added to Russell 3000E Growth Benchmark - marketscreener.com
-
Larimar Therapeutics: Late-Stage FA Program Advances Amid Execution Risks (NASDAQ:LRMR) - Seeking Alpha
-
Larimar Therapeutics (LRMR) Is Up 85.9% After Breakthrough Status For Nomlabofusp In Friedreich’s Ataxia - simplywall.st
-
Why Did Larimar Therapeutics’ Stock Surge Over 30% Pre-Market Today? - Stocktwits
-
Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results - Yahoo Finance
-
Larimar Therapeutics jumps on FDA Breakthrough Therapy Designation for nomlabofusp - Quiver Quantitative
-
Larimar Prices $100M Stock Sale After Record Rally Fueled By FDA Breakthrough Tag For Protein Replacement Therapy - Stocktwits
-
Citizens reiterates Larimar Therapeutics stock rating on FDA progress - Investing.com
-
Larimar Therapeutics stockholders approve board elections and share increase - Investing.com
-
Larimar Therapeutics wins FDA Breakthrough Therapy Designation for nomlabofusp; BLA on track for June 2026 - TradingView
-
Larimar Therapeutics (LRMR) entity tied to director receives 55,150 stock options - Stock Titan
-
Larimar Stock Slides 15% Despite FDA Backing Rolling Submission For Rare Disease Drug - Benzinga
-
Larimar Therapeutics: Deerfield entities buy $25m in stock - Investing.com
-
Larimar Therapeutics: The Market Is Mispricing A Potential Standard Of Care (NASDAQ:LRMR) - Seeking Alpha
-
We Think Larimar Therapeutics (NASDAQ:LRMR) Needs To Drive Business Growth Carefully - simplywall.st
-
What Just Happened with Larimar Therapeutics (LRMR) and Why Does it Matter - Kavout | AI
-
LRMR Forecast — Price Target — Prediction for 2027 - TradingView
-
Friedreich's Ataxia: The Search For A True Disease-Modifying Therapy - Can Larimar Deliver? - RTTNews
-
Larimar’s Stock Soars After FDA Grants Breakthrough Therapy Designation - StocksToTrade
-
Larimar surges on FDA breakthrough status for lead asset - Seeking Alpha
-
Larimar Therapeutics Stock Surges Following Impressive Financial Indicators - StocksToTrade
-
CLERHP Unveils the First Smart City in the Dominican Republic with the Inauguration of Larimar City & Resort - Business Wire
-
National Larimar Day – Nov. 22, 2026 - National Today
-
Larimar Therapeutics Initiates BLA Submission for Nomlabofusp in Friedreich’s Ataxia - Profit Guidance Range - dars.gov.et
-
Larimar Therapeutics, Inc. Stock 12‑Month Price Target Cut to $15.88, Implies 287% Upside - TradingView
-
Larimar Therapeutics Files First Module of BLA for Nomlabofusp in Friedreich's Ataxia Treatment - New Analyst Coverage - dars.gov.et
-
Larimar Therapeutics director buys $166,890 in company stock By Investing.com - Investing.com Canada
-
CLERHP Strengthens Larimar City & Resort as One of the Leading International Projects at FITUR - Business Wire
-
LRMR Stock Edges Up After Hours After Director Purchases Shares Worth About $167,000 - TradingView
-
Larimar Therapeutics stock surges on FDA breakthrough status By Investing.com - Investing.com Nigeria
-
Shares of Bala Cynwyd biotech soar as FDA filing nears for rare disease drug - The Business Journals
-
Local biotechs capitalize on soaring share prices, raise a combined $345M in stock sales - The Business Journals
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR - PR Newswire
-
Blue Owl (NASDAQ: LRMR) discloses 9.99% position totaling 10.74M shares - Stock Titan
-
Dominican Republic boosts rare earths and emblematic blue stone as it consolidates key projects - BNamericas
-
Larimar Therapeutics stock jumps on insider purchase By Investing.com - Investing.com UK
-
Ring Sterling Silver Ring 925 Larimar Stein Ring Blue Larimar Gemstone Ring 925 Sterling Silver Bezel Set Men's Ring All Size - มูลนิธิเพื่อผู้บริโภค มพบ.
-
Larimar Therapeutics' stock price tumbles on mixed study results for lead drug candidate - The Business Journals
-
Nomlabofusp leads to long-term frataxin gains for FA patients: Data - Friedreich's Ataxia News
-
Larimar Therapeutics stock tumbles after clinical data release By Investing.com - Investing.com India
-
Muñoz Family Expands Culinary Legacy with Opening of Larimar Seafood and Steakhouse - The San Pedro Sun
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR - PR Newswire
-
Steven Todrys, Riki Kane Larimar, and Karol Todrys Photo (July 1, 2024) - BroadwayWorld
-
Inaugural Smart Cities - Trend Hunter
-
Larimar above par in FA despite anaphylaxis penalty - BioWorld News
-
Larimar Therapeutics Closes $69 Million Public Offering of Common Stock to Support Development of Pipeline Candidates - Quiver Quantitative
-
Larimar Therapeutics Announces Proposed Underwritten Public Offering - GlobeNewswire
-
Larimar Therapeutics Stock (LRMR) Opinions on Public Offering Announcement - Quiver Quantitative
-
Larimar Therapeutics (LRMR) Holds Steady Near Support After Modest Gain - Triple Top - dars.gov.et
-
Larimar Therapeutics Edges Higher as Shares Test Key Resistance Zone - Fundamental Weighted - dars.gov.et
-
Larimar resumes nomlabofusp programme after FDA lifts partial hold - Clinical Trials Arena
-
Larimar's Friedreich’s ataxia program free at last from FDA hold - Fierce Biotech
-
Larimar Therapeutics launches public offering of common stock - Investing.com
-
The Bluest Stone (Published 2022) - The New York Times
-
Larimar Therapeutics (LRMR) Holds Steady Near Support After Modest Gain - Protective Put - dars.gov.et
-
Opinion: Larimar Could Compete with Biogen in Friedreich’s Ataxia - BioSpace
-
symbol__ Stock Quote Price and Forecast - CNN
-
Larimar Therapeutics (LRMR) Holds Steady Near Support After Modest Gain - Overvalued Signals - dars.gov.et
-
Larimar Fiallo announces she will be a mother for the second time - De Último Minuto
-
Yener Yat motor yacht Larimar for sale - BOAT International
-
Learn about larimar, rare blue gem found only in the Dominican Republic - CBS News
-
Larimar Therapeutics (LRMR) Slides 4.3% as Selling Pressure Tests Key Support - Social Sentiment - dars.gov.et
-
Larimar lays out FDA approval plan for Friedreich’s ataxia drug - Clinical Trials Arena
-
Larimar Therapeutics prices $60M stock offering - MSN
-
Watch CBS Saturday Morning: The story behind rare blue gem larimar - CBS
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.